$2.30
▼ -16.4% Today
as of Oct 22, 16:50 ET
Last 30 days
Recent Press Releases & News
DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
DataMeds Regains Compliance With NASDAQ Listing Standards
DataMeds AI Plans Peptide Compounding Expansion Through Corexa Health Following FDA Policy Proposal
MEDS earnings at a glance
The share price of $2.30 sits near its 52-week low.
Overview
52-week range
$0.82
$73
2% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-7.13 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-0.07 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.46 | — | — | — | — | financials |
| Tue Aug 19, 2025 | Jun/2025 | $-0.11 | — | — | — | — | earnings |
| Mon Mar 31, 2025 | Mar 2025 | $-0.62 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.04 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.01 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | — | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | — | $3M | $8M | $11M | $6M | $44,540 |
| Cost of revenue | $2M | $1M | — | $3M | $7M | $10M | $5M | $47,148 |
| Gross profit | $182,204 | $170,221 | — | $231,012 | $505,752 | $692,641 | $521,244 | $-2,608 |
| Operating income | $-7M | $-6M | — | $-32M | $-6M | $-31M | $-2M | $-573,016 |
| Net income | $-18M | $-8M | — | $-34M | $-7M | $-32M | $-2M | $-574,325 |
| EPS (diluted) | $-7.13 | $-0.07 | — | $-0.46 | $-5.40 | $-0.62 | $-0.04 | $-0.01 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2M | $51,730 | $42,571 | $4M | $419,942 | $3M | — | — |
| Inventory | $2M | $2M | $2M | $7M | $9M | $10M | — | — |
| Total current assets | $6M | $3M | $3M | $13M | $14M | $17M | — | — |
| Total assets | $33M | $30M | $30M | $53M | $54M | $58M | — | — |
| Long-term debt | $13M | $13M | $13M | $13M | $10M | $24M | — | — |
| Total liabilities | $52M | $45M | $43M | $46M | $53M | $54M | — | — |
| Total equity | $-20M | $-15M | $-12M | $7M | $905,255 | $4M | $10M | $-3M |
Implied volatility — last 90 days
No IV snapshots yet for MEDS.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.